Evidence map›Paper›PMID 30398950›Full record

ArticleJournal of global oncology2018

Feasibility of Patient Navigation to Improve Breast Cancer Care in Malaysia.

Zi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Sakthi Maniam, Ushananthiny Suvelayutnan, Rahani Yaacob and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of global oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
1.1field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Coordination Models for Cancer Care in Low- and Middle-Income Countries: A Scoping Review.International journal of environmental research and public health · 2022
    Article
  14. Article
  15. Article
  16. Development and evaluation of a sustainable video health education program for newly diagnosed breast cancer patients in Malaysia.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Zi-Yi YeohZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Maheswari JaganathanZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Nadia RajaramZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Sudha RawatZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Nurul Ain TajudeenZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Norlia RahimZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Nur Hidayati ZainalZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Sakthi ManiamZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Ushananthiny SuvelayutnanZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Rahani YaacobZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Vijayalakshmi KrishnapillaiZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Meor Zamari Meor KamalZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Soo-Hwang TeoZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Mohamed Yusof Abdul WahabZi-Yi Yeoh, Maheswari Jaganathan, Nadia Rajaram, Sakthi Maniam, and Soo-Hwang Teo, Cancer Research Malaysia; Sudha Rawat, Nurul Ain Tajudeen, Norlia Rahim, Nur Hidayati Zainal, Ushananthiny Suvelayutnan, Rahani Yaacob, Vijayalakshmi Krishnapillai, Meor Zamari Meor Kamal, and Mohamed Yusof Abdul Wahab, Hospital Tengku Ampuan Rahimah, Selangor; and Soo-Hwang Teo, University Malaya Cancer Research Institute, Kuala Lumpur, Malaysia.
Cancer Research Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeLate stage at presentation and poor adherence to treatment remain major contributors to poor survival in low- and middle-income countries (LMICs). Patient navigation (PN) programs in the United States have led to improvement in diagnostic or treatment timeliness, particularly for women in lower socioeconomic classes or minority groups. To date, studies of PN in Asia have been limited. We aimed to assess the feasibility of PN in a state-run hospital in an LMIC and to report the impact on diagnostic and treatment timeliness for patients in its first year of implementation.

methodsWe established PN in a dedicated breast clinic of a Malaysian state-run hospital. We compared diagnostic and treatment timeliness between navigated patients (n = 135) and patients diagnosed in the prior year (n = 148), and described factors associated with timeliness.

resultsWomen with PN received timely mammography compared with patients in the prior year (96.4% v 74.4%; P < .001), biopsy (92.5% v 76.1%; P = .003), and communication of news (80.0% v 58.5%; P < .001). PN reduced treatment default rates (4.4% v 11.5%; P = .048). Among navigated patients, late stage at presentation was independently associated with having emotional and language barriers ( P = .01). Finally, the main reason reported for delay, default, or refusal of treatment was the preference for alternative therapy.

conclusionPN is feasible for addressing barriers to cancer care when integrated with a state-run breast clinic of an LMIC. Its implementation resulted in improved diagnostic timeliness and reduced treatment default. Wider adoption of PN could be a key element of cancer control in LMICs.

Indexed as

Breast NeoplasmsFeasibility StudiesFemaleHumansMalaysiaPatient Navigation

Identifiers

PMID30398950
PMCPMC7010457
OpenAlexW2899518396

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.